Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Fridlyand

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cancer Research|April 3, 2004
Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomasJeffrey H Hager, J Graeme Hodgson, Jane Fridlyand, et al.
BMC Cancer|October 29, 2010
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic dataErich P Huang, Jane Fridlyand, Nicholas Lewin-Koh, et al.
Genetic Testing|January 27, 2007
Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancerYing Chen, Amanda E Toland, Jane McLennan, et al.
Genome Biology|June 23, 2007
Genome position and gene amplificationPavla Gajduskova, Antoine M Snijders, Serena Kwek, et al.
Oncogene|April 13, 2005
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinomaAntoine M Snijders, Brian L Schmidt, Jane Fridlyand, et al.
Oncogene|July 11, 2003
Shaping of tumor and drug-resistant genomes by instability and selectionAntoine M Snijders, Jane Fridlyand, Dorus A Mans, et al.
Hepatology (Baltimore, Md.)|January 25, 2008
Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancerSusie A Lee, Coral Ho, Ritu Roy, et al.
Genes, Chromosomes & Cancer|October 18, 2006
Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approachChristoph Thorns, Boris Bastian, Daniel Pinkel, et al.
Genes, Chromosomes & Cancer|March 13, 2008
High-resolution genomic and expression analyses of copy number alterations in breast tumorsPeter M Haverty, Jane Fridlyand, Li Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2002
Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic miceR C Andrew Symons, Mark J Daly, Jane Fridlyand, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cancer Research|April 3, 2004
Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomasJeffrey H Hager, J Graeme Hodgson, Jane Fridlyand, et al.
BMC Cancer|October 29, 2010
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic dataErich P Huang, Jane Fridlyand, Nicholas Lewin-Koh, et al.
Genetic Testing|January 27, 2007
Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancerYing Chen, Amanda E Toland, Jane McLennan, et al.
Genome Biology|June 23, 2007
Genome position and gene amplificationPavla Gajduskova, Antoine M Snijders, Serena Kwek, et al.
Oncogene|April 13, 2005
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinomaAntoine M Snijders, Brian L Schmidt, Jane Fridlyand, et al.
Oncogene|July 11, 2003
Shaping of tumor and drug-resistant genomes by instability and selectionAntoine M Snijders, Jane Fridlyand, Dorus A Mans, et al.
Hepatology (Baltimore, Md.)|January 25, 2008
Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancerSusie A Lee, Coral Ho, Ritu Roy, et al.
Genes, Chromosomes & Cancer|October 18, 2006
Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approachChristoph Thorns, Boris Bastian, Daniel Pinkel, et al.
Genes, Chromosomes & Cancer|March 13, 2008
High-resolution genomic and expression analyses of copy number alterations in breast tumorsPeter M Haverty, Jane Fridlyand, Li Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2002
Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic miceR C Andrew Symons, Mark J Daly, Jane Fridlyand, et al.
Pageof 6